105 related articles for article (PubMed ID: 9600640)
1. Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells.
Zucker TP; Bönisch D; Hasse A; Grosser T; Weber AA; Schrör K
Eur J Pharmacol; 1998 Mar; 345(2):213-20. PubMed ID: 9600640
[TBL] [Abstract][Full Text] [Related]
2. Iloprost-induced inhibition of proliferation of coronary artery smooth muscle cells is abolished by homologous desensitization.
Grosser T; Bönisch D; Zucker TP; Schrör K
Agents Actions Suppl; 1995; 45():85-91. PubMed ID: 7536386
[TBL] [Abstract][Full Text] [Related]
3. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins.
Sussmann M; Sarbia M; Meyer-Kirchrath J; Nüsing RM; Schrör K; Fischer JW
Circ Res; 2004 Mar; 94(5):592-600. PubMed ID: 14752026
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells.
Wharton J; Davie N; Upton PD; Yacoub MH; Polak JM; Morrell NW
Circulation; 2000 Dec; 102(25):3130-6. PubMed ID: 11120706
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor.
Li RC; Cindrova-Davies T; Skepper JN; Sellers LA
Circ Res; 2004 Apr; 94(6):759-67. PubMed ID: 14963006
[TBL] [Abstract][Full Text] [Related]
6. Role of potassium channels and nitric oxide in the effects of iloprost and prostaglandin E1 on hypoxic vasoconstriction in the isolated perfused lung of the rat.
Dumas M; Dumas JP; Rochette L; Advenier C; Giudicelli JF
Br J Pharmacol; 1997 Feb; 120(3):405-10. PubMed ID: 9031743
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vasodilatory prostaglandins with respect to cAMP-mediated phosphorylation of a target substrate in intact human platelets.
Nolte C; Eigenthaler M; Schanzenbächer P; Walter U
Biochem Pharmacol; 1991 Jul; 42(2):253-62. PubMed ID: 1713458
[TBL] [Abstract][Full Text] [Related]
8. Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins.
Rabausch K; Bretschneider E; Sarbia M; Meyer-Kirchrath J; Censarek P; Pape R; Fischer JW; Schrör K; Weber AA
Circ Res; 2005 Jan; 96(1):e1-6. PubMed ID: 15591227
[TBL] [Abstract][Full Text] [Related]
9. The prostacyclin analogue iloprost and prostaglandin E1 suppress sterol synthesis in freshly isolated human mononuclear leukocytes.
Krone W; Kaczmarczyk P; Müller-Wieland D; Greten H
Biochim Biophys Acta; 1985 Jun; 835(1):154-7. PubMed ID: 2408673
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
11. Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A.
Bönisch D; Weber AA; Wittpoth M; Osinski M; Schrör K
Mol Pharmacol; 1998 Aug; 54(2):241-8. PubMed ID: 9687564
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cyclooxygenase-2 expression by iloprost in human vascular smooth muscle cells. Role of transcription factors CREB and ICER.
Debey S; Meyer-Kirchrath J; Schrör K
Biochem Pharmacol; 2003 Mar; 65(6):979-88. PubMed ID: 12623129
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of prostaglandin E1 on intimal thickening following photochemically induced endothelial injury in the rat femoral artery.
Umemura K; Watanabe S; Kondo K; Hashimoto H; Nakashima M
Atherosclerosis; 1997 Apr; 130(1-2):11-6. PubMed ID: 9126643
[TBL] [Abstract][Full Text] [Related]
14. Studies on the induction of cyclooxygenase isozymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduction pathways.
Takahashi Y; Taketani Y; Endo T; Yamamoto S; Kumegawa M
Biochim Biophys Acta; 1994 May; 1212(2):217-24. PubMed ID: 7514040
[TBL] [Abstract][Full Text] [Related]
15. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle related inhibition of mouse vascular smooth muscle cell proliferation by prostaglandin E1: relationship between prostaglandin E1 and intracellular cAMP levels.
Fan YY; Ramos KS; Chapkin RS
Prostaglandins Leukot Essent Fatty Acids; 1996 Feb; 54(2):101-7. PubMed ID: 8848428
[TBL] [Abstract][Full Text] [Related]
17. Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs.
Schermuly RT; Pullamsetti SS; Breitenbach SC; Weissmann N; Ghofrani HA; Grimminger F; Nilius SM; Schrör K; Kirchrath JM; Seeger W; Rose F
Respir Res; 2007 Jan; 8(1):4. PubMed ID: 17257398
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
19. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M
Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
[TBL] [Abstract][Full Text] [Related]
20. Evidence that Ca2+-activated K+ channels play a major role in mediating the vascular effects of iloprost and cicaprost.
Clapp LH; Turcato S; Hall S; Baloch M
Eur J Pharmacol; 1998 Sep; 356(2-3):215-24. PubMed ID: 9774252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
